In: Human Reproduction Update, 2016, vol. 22, no. 3, p. 382-403
|
In: Journal of Molecular Medicine, 2015, vol. 93, no. 10, p. 1061-1073
|
In: Journal of Mammary Gland Biology and Neoplasia, 2006, vol. 11, no. 1, p. 53-61
|
In: Annals of Oncology, 2009, vol. 20, p. vi35-vi40
|
In: Nephrology Dialysis Transplantation, 2006, vol. 21, no. 3, p. 598-604
|
In: Brain, 2009, vol. 132, no. 6, p. 1509-1522
|
In: Obesity Reviews, 2012, vol. 13, no. S2, p. 58–68
The continuing increase in the prevalence of obesity and metabolic disorders such as type-II diabetes and an accelerating aging population globally will remain the major contributors to cardiovascular mortality and morbidity in the 21st century. It is well known that aging is highly associated with metabolic and cardiovascular diseases. Growing evidence also shows that obesity and metabolic...
|
In: Frontiers in Vascular Physiology, 2012, vol. 3, p. 5
The global population aging is accelerating and age-associated diseases including cardiovascular diseases become more challenging. The underlying mechanisms of aging and age-associated cardiovascular dysfunction remain elusive. There are substantial evidences demonstrating a pivotal role of the mammalian target of rapamycin complex 1 (mTORC1) and its down-stream effector S6K1 signaling in...
|
In: Febs Letters, 2010, vol. 58, no. 1, p. 135-140
Rapamycin has been reported to enhance tissue factor (TF) expression. The present study investigated roles of mammalian target of rapamycin (mTOR) and its downstream S6K1 in this process. We showed here that, consistent with rapamycin, knocking-down mTOR enhanced thrombin-induced TF mRNA and protein levels, whereas silencing S6K1 mitigated up-regulation of TF protein but not TF mRNA level. The...
|